References
- Ashrafi MR, Tavasoli AR. Childhood leukodystrophies: a literature review of updates on new definitions, classification, diagnostic approach, and management. Brain Dev. 2017;39(5):369–385. doi:10.1016/j.braindev.2017.01.001.
- Pouwels PJ, Vanderver A, Bernard G, et al. Hypomyelinating leukodystrophies: translational research progress and prospects. Ann Neurol. 2014;76(1):5–19. doi:10.1002/ana.24194.
- Biancheri R, Rosano C, Denegri L, et al. Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form. Eur J Hum Genet. 2013;21(1):34–39. doi:10.1038/ejhg.2012.93.
- Nahhas N, Conant A, Orthmann-Murphy J, Vanderver A, Hobson G. Pelizaeus-Merzbacher-Like Disease 1. In: Adam MP, eds. et al. GeneReviews®. Seattle: University of Washington; 2017.
- Castro MAA, Fraiman PHA, Godeiro-Junior CO. Magnetic resonance imaging traits may help to differentiate Pelizaeus-Merzbacher and Pelizaeus-Merzbacher-like disease. Arq NeuroPsiquiatr. 2019;77(8):594. doi:10.1590/0004-282X20190081.
- Abrams CK. Mechanisms of diseases associated with mutation in GJC2/Connexin 47. Biomolecules. 2023;13(4):712. doi:10.3390/biom13040712.
- Vaurs-Barrière C, Deville M, Sarret C, et al. Pelizaeus-Merzbacher-like disease presentation of MCT8 mutated male subjects. Ann Neurol. 2009;65(1):114–118. doi:10.1002/ana.21579.
- Feinstein M, Markus B, Noyman I, et al. Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. Am J Hum Genet. 2010;87(6):820–828. doi:10.1016/j.ajhg.2010.10.016.
- Lossos A, Elazar N, Lerer I, et al. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder. Brain. 2015;138(Pt 9):2521–2536. doi:10.1093/brain/awv204.
- Llaci L, Ramsey K, Belnap N, et al. Compound heterozygous mutations in SNAP29 are associated with Pelizaeus-Merzbacher-like disorder (PMLD). Hum Genet. 2019;138(11–12):1409–1417. doi:10.1007/s00439-019-02077-7.
- Fu H, Wang Q, Liu H. Novel mutations in NPC1 are associated with Pelizaeus-Merzbacher-like disease: a case report. Int J Gen Med. 2021;14:797–803. doi:10.2147/IJGM.S293675.
- Alfadhel M, Almuqbil M, Al Mutairi F, et al. The leukodystrophy spectrum in Saudi Arabia: epidemiological, clinical, radiological, and genetic data. Front Pediatr. 2021;9:633385. doi:10.3389/fped.2021.633385.
- Ji H, Li D, Wu Y, et al. Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients. PloS One. 2018;13(2):e0188869. doi:10.1371/journal.pone.0188869.
- Mahdieh N, Soveizi M, Tavasoli AR, et al. Genetic testing of leukodystrophies unraveling extensive heterogeneity in a large cohort and report of five common diseases and 38 novel variants. Sci Rep. 2021;11(1):3231. doi:10.1038/s41598-021-82778-0.
- Henneke M, Gegner S, Hahn A, et al. Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease. Neurology. 2010;74(22):1785–1789. doi:10.1212/WNL.0b013e3181e0f820.